Fatemeh Saberi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fatemeh Saberi has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Hanie Babaie
Autoimmune Bullous Diseases Research Center, Razi Hospital Tehran University of Medical Sciences Tehran Iran
3 shared publications Kambiz Kamyab
Department of Dermatopathology, Razi Hospital Tehran University of Medical Sciences Tehran Iran
2 shared publications- Maryam Nasimi
Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Shahin Hamzelou
Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 shared publications - Zeinab Aryanian
Autoimmune Bullous Disease Research Center, Razi Hospital Tehran University of Medical Sciences Tehran Iran
2 shared publications Abolfazl Zendedel
Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences Tehran Iran
1 shared publication
Latest Publications
- Open Access
- 25 July 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8)
Clinicopathological Features of Lupus Erythematosus Panniculitis (LEP): A Retrospective Analysis of 54 Cases
Background: Lupus Erythematosus Panniculitis (LEP) is a rare subtype of Cutaneous Lupus Erythematosus. It is a challenging disease to diagnose and treat due to limited understanding of its clinical and histopathological characteristics. Methods: We conducted a retrospective review of 54 biopsy‐proven LEP cases evaluated at a dermatology referral center from 2016 to 2022. Demographic, clinical, laboratory, and treatment data were extracted from medical records, and histopathologic features were reassessed when slides required further characterization. Direct immunofluorescence and serologic results were recorded when available. Statistical analyses were performed using SPSS (v26), with significance defined as p < 0.05. Results: Fifty‐four patients with LEP (female‐to‐male ratio 5:1; mean age 38.8 ± 14.7 years) were included. Coexistent systemic lupus erythematosus (SLE) was present in 24.1% of cases. Delayed diagnosis was significantly associated with lipoatrophy ( p < 0.001). Histopathologic findings most commonly included lymphocytic vasculitis (72.2%), histologic features of discoid lupus erythematosus (68.5%), and lobular panniculitis (63%). ANA, anti‐double‐stranded DNA, and direct immunofluorescence were positive in 24.1%, 16.6%, and 72.2% of patients, respectively. Overall, 85.2% of patients improved clinically. Hydroxychloroquine combined with corticosteroids and mycophenolate mofetil was associated with the highest improvement rates, whereas intralesional corticosteroid therapy appeared least effective, although differences were not statistically significant. Conclusion: It is essential to evaluate the clinical and histopathologic features of patients accurately before diagnosis. Delay in diagnosis may be more common in patients without associated SLE or DLE, although these associations were not statistically significant in our cohort. Hydroxychloroquine‐based combination therapy, particularly with corticosteroids and mycophenolate mofetil, was associated with favorable clinical outcomes, although prospective studies are needed to establish optimal treatment strategies.
- 25 July 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (8)
Open AccessClinicopathological Features of Lupus Erythematosus Panniculitis (LEP): A Retrospective Analysis of 54 Cases
Background: Lupus Erythematosus Panniculitis (LEP) is a rare subtype of Cutaneous Lupus Erythematosus. It is a challenging disease to diagnose and treat due to limited understanding of its clinical and histopathological characteristics. Methods: We conducted a retrospective review of 54 biopsy‐proven LEP cases evaluated at a dermatology referral center from 2016 to 2022. Demographic, clinical, laboratory, and treatment data were extracted from medical records, and histopathologic features were reassessed when slides required further characterization. Direct immunofluorescence and serologic results were recorded when available. Statistical analyses were performed using SPSS (v26), with significance defined as p < 0.05. Results: Fifty‐four patients with LEP (female‐to‐male ratio 5:1; mean age 38.8 ± 14.7 years) were included. Coexistent systemic lupus erythematosus (SLE) was present in 24.1% of cases. Delayed diagnosis was significantly associated with lipoatrophy ( p < 0.001). Histopathologic findings most commonly included lymphocytic vasculitis (72.2%), histologic features of discoid lupus erythematosus (68.5%), and lobular panniculitis (63%). ANA, anti‐double‐stranded DNA, and direct immunofluorescence were positive in 24.1%, 16.6%, and 72.2% of patients, respectively. Overall, 85.2% of patients improved clinically. Hydroxychloroquine combined with corticosteroids and mycophenolate mofetil was associated with the highest improvement rates, whereas intralesional corticosteroid therapy appeared least effective, although differences were not statistically significant. Conclusion: It is essential to evaluate the clinical and histopathologic features of patients accurately before diagnosis. Delay in diagnosis may be more common in patients without associated SLE or DLE, although these associations were not statistically significant in our cohort. Hydroxychloroquine‐based combination therapy, particularly with corticosteroids and mycophenolate mofetil, was associated with favorable clinical outcomes, although prospective studies are needed to establish optimal treatment strategies.
- Open Access
- 5 May 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (5)
Evaluation of the Complete Blood Count (CBC) Parameters in Patients With Hidradenitis Suppurativa and Their Correlation With Disease Severity: A Cross‐Sectional Study
Background and Aim: Hidradenitis suppurativa is a chronic inflammatory skin disease characterized by painful, recurrent lesions most commonly affecting the axillary, groin, and inframammary areas. This study aimed to evaluate CBC parameters in HS patients and analyze their correlation with disease severity to identify potential biomarkers of systemic inflammation. Methods: The current cross‐sectional study compared 75 diagnosed HS patients with 75 healthy individuals. CBC parameters included WBC count, RBC count, platelet count, and their respective derived ratios: NLR and PLR. The severity of HS was assessed by SAHS scores and staging of the disease. The various blood markers were compared across groups and analyzed for correlations among each other, the disease severity and stage, and demographic factors. Results: As for the CBC parameters in HS patients as compared with healthy controls, the following were the levels expressed in the study: higher RBC, higher platelets and mean platelet volume or MPV, besides lowered parameters of red blood cell distribution width or RDW, mean corpuscular volume or MCV and mean corpuscular hemoglobin or MCH with corresponding p ‐values of p = 0.01, p = 0.001 and p = 0.002, along with p < 0.0001 in each. However, no significant differences were seen in NLR ( p = 0.55) and PLR ( p = 0.73). Curiously, higher levels of RBCs were associated with less severe forms of the disease ( r = −0.26, p = 0.02), while male patients tended to have higher levels of RBCs and hemoglobin compared with females ( p < 0.001). Conclusion: Specifically, the CBC parameters of RBC, RDW, MCV, and MCH were significantly different in HS patients and may thus represent more accessible markers of inflammation and activity. This study sets a promising role for CBC markers in the personalization of care in HS but confirmation of their value in larger populations is still needed.
- 5 May 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (5)
Open AccessEvaluation of the Complete Blood Count (CBC) Parameters in Patients With Hidradenitis Suppurativa and Their Correlation With Disease Severity: A Cross‐Sectional Study
Background and Aim: Hidradenitis suppurativa is a chronic inflammatory skin disease characterized by painful, recurrent lesions most commonly affecting the axillary, groin, and inframammary areas. This study aimed to evaluate CBC parameters in HS patients and analyze their correlation with disease severity to identify potential biomarkers of systemic inflammation. Methods: The current cross‐sectional study compared 75 diagnosed HS patients with 75 healthy individuals. CBC parameters included WBC count, RBC count, platelet count, and their respective derived ratios: NLR and PLR. The severity of HS was assessed by SAHS scores and staging of the disease. The various blood markers were compared across groups and analyzed for correlations among each other, the disease severity and stage, and demographic factors. Results: As for the CBC parameters in HS patients as compared with healthy controls, the following were the levels expressed in the study: higher RBC, higher platelets and mean platelet volume or MPV, besides lowered parameters of red blood cell distribution width or RDW, mean corpuscular volume or MCV and mean corpuscular hemoglobin or MCH with corresponding p ‐values of p = 0.01, p = 0.001 and p = 0.002, along with p < 0.0001 in each. However, no significant differences were seen in NLR ( p = 0.55) and PLR ( p = 0.73). Curiously, higher levels of RBCs were associated with less severe forms of the disease ( r = −0.26, p = 0.02), while male patients tended to have higher levels of RBCs and hemoglobin compared with females ( p < 0.001). Conclusion: Specifically, the CBC parameters of RBC, RDW, MCV, and MCH were significantly different in HS patients and may thus represent more accessible markers of inflammation and activity. This study sets a promising role for CBC markers in the personalization of care in HS but confirmation of their value in larger populations is still needed.
- 17 April 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 150
Targeted metabolomics investigation of serum levels of fatty acid metabolites in pemphigus vulgaris patients and healthy individuals
- 17 April 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 150
Targeted metabolomics investigation of serum levels of fatty acid metabolites in pemphigus vulgaris patients and healthy individuals
- Open Access
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Smoking and Nail Psoriasis: Examining the Connection in a Case‐Control Study
Background: Nail psoriasis (NP) significantly affects patients’ quality of life and is associated with psoriasis severity. Smoking is a preventable risk factor that has been tied to poor disease outcomes, but its effect on NP is not well established. The purpose of this work is to analyze the connection between smoking and NP severity and occurrence. Methods: For this case‐control study, 218 psoriasis patients and 218 controls were enrolled. The smoking history was collected, including the time and number of cigarettes smoked per day. The Nail Psoriasis Severity Index (NAPSI) was used to assess the severity of NP. In contrast, the Psoriasis Area and Severity Index (PASI) was used to evaluate the overall severity of psoriasis. Results: The results of the study showed that the prevalence of smoking was higher among the patients with psoriasis (27.5%) as compared to controls (6.0%; p < 0.001). Among the psoriasis group, current smokers had more severe NP than nonsmokers (23.8 ± 18.6 vs. 12.3 ± 11.2, p = 0.001) as assessed by NAPSI. PASI and the incidence of psoriatic arthritis were not significantly influenced by smoking. Conclusion: In conclusion, our results suggest that smoking is significantly associated with increased severity of NP. These results highlight the importance of incorporating smoking cessation in psoriasis patients’ care. Our study adds to the body of literature that highlights the importance of lifestyle changes such as smoking cessation for the improvement of NP. Prospective studies are required to investigate the impact of smoking cessation on the development and severity of NP.
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Open AccessSmoking and Nail Psoriasis: Examining the Connection in a Case‐Control Study
Background: Nail psoriasis (NP) significantly affects patients’ quality of life and is associated with psoriasis severity. Smoking is a preventable risk factor that has been tied to poor disease outcomes, but its effect on NP is not well established. The purpose of this work is to analyze the connection between smoking and NP severity and occurrence. Methods: For this case‐control study, 218 psoriasis patients and 218 controls were enrolled. The smoking history was collected, including the time and number of cigarettes smoked per day. The Nail Psoriasis Severity Index (NAPSI) was used to assess the severity of NP. In contrast, the Psoriasis Area and Severity Index (PASI) was used to evaluate the overall severity of psoriasis. Results: The results of the study showed that the prevalence of smoking was higher among the patients with psoriasis (27.5%) as compared to controls (6.0%; p < 0.001). Among the psoriasis group, current smokers had more severe NP than nonsmokers (23.8 ± 18.6 vs. 12.3 ± 11.2, p = 0.001) as assessed by NAPSI. PASI and the incidence of psoriatic arthritis were not significantly influenced by smoking. Conclusion: In conclusion, our results suggest that smoking is significantly associated with increased severity of NP. These results highlight the importance of incorporating smoking cessation in psoriasis patients’ care. Our study adds to the body of literature that highlights the importance of lifestyle changes such as smoking cessation for the improvement of NP. Prospective studies are required to investigate the impact of smoking cessation on the development and severity of NP.
- Open Access
- 4 August 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (8)
A Case Report of Recalcitrant, Extensive Multifocal Epithelial Hyperplasia Treated by Electrocauterization
Multifocal epithelial hyperplasia is a very rare, benign, contagious disease of the oral mucosa caused by infection with a specific genotype of human papillomavirus. It presents with asymptomatic, smooth‐surfaced papules or nodules in the mouth of children and adults. In many cases of multifocal epithelial hyperplasia, a “wait‐and‐see” approach may be sufficient. However, more aggressive treatments, such as destructive modalities, may be necessary for extensive lesions. Multiple destructive modalities have been used in the treatment of multifocal epithelial hyperplasia with variable results; here we report the significant effect of electrocautery in clearing widespread mucosal lesions of multifocal epithelial hyperplasia in a 15‐year‐old male patient who had multiple sessions of cryotherapy without clearance.
- 4 August 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (8)
Open AccessA Case Report of Recalcitrant, Extensive Multifocal Epithelial Hyperplasia Treated by Electrocauterization
Multifocal epithelial hyperplasia is a very rare, benign, contagious disease of the oral mucosa caused by infection with a specific genotype of human papillomavirus. It presents with asymptomatic, smooth‐surfaced papules or nodules in the mouth of children and adults. In many cases of multifocal epithelial hyperplasia, a “wait‐and‐see” approach may be sufficient. However, more aggressive treatments, such as destructive modalities, may be necessary for extensive lesions. Multiple destructive modalities have been used in the treatment of multifocal epithelial hyperplasia with variable results; here we report the significant effect of electrocautery in clearing widespread mucosal lesions of multifocal epithelial hyperplasia in a 15‐year‐old male patient who had multiple sessions of cryotherapy without clearance.
- 13 February 2025
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 52 (5) , 386-391
Clinical and Histopathological Insights Into Lupus Miliaris Disseminatus Faciei: A Review of 70 Cases
Background: Lupus miliaris disseminatus faciei (LMDF) is a granulomatous inflammatory disease often manifesting on the face as red, brown, or yellow papules. Lesions can cause scarring and disfigurement. There is no standard treatment due to a limited understanding of the etiology. Method: This review examines the clinical and histopathological characteristics of 70 LMDF patients who were diagnosed from 2016 to 2022. Results: The patients' mean age was 32.43, with a majority being in their 20s and 30s. Females were more affected during the fourth decade and beyond. The average disease duration among patients was 7.2 months. All of them had facial involvement, mostly around the eyes and on the eyelids. Histopathological analysis revealed epithelioid granulomas with inflammatory cell infiltration and, in some cases, central caseous necrosis. A relationship between the granuloma and the pilosebaceous unit was seen in 75.7% of cases. Epidermal changes, like acanthosis, were found in 47.1% of cases. We also report the existence of linear vessels in 25 (35.7%) cases. Conclusion: Most authors now consider LMDF a distinct entity, but because of its resemblance to other diseases like granulomatous rosacea, the diagnosis is challenging. Unlike many studies in this field, we provide a quite large sample and report telangiectasia in LMDF patients, which highlights the importance of precisely differentiating LMDF from rosacea. Delay in diagnosis and treatment increases the risk of scarring. Overall, we believe this study provides valuable insights into the demographics and histopathology of LMDF, contributing to the understanding of this challenging skin disorder.
- 13 February 2025
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 52 (5) , 386-391
Clinical and Histopathological Insights Into Lupus Miliaris Disseminatus Faciei: A Review of 70 Cases
Background: Lupus miliaris disseminatus faciei (LMDF) is a granulomatous inflammatory disease often manifesting on the face as red, brown, or yellow papules. Lesions can cause scarring and disfigurement. There is no standard treatment due to a limited understanding of the etiology. Method: This review examines the clinical and histopathological characteristics of 70 LMDF patients who were diagnosed from 2016 to 2022. Results: The patients' mean age was 32.43, with a majority being in their 20s and 30s. Females were more affected during the fourth decade and beyond. The average disease duration among patients was 7.2 months. All of them had facial involvement, mostly around the eyes and on the eyelids. Histopathological analysis revealed epithelioid granulomas with inflammatory cell infiltration and, in some cases, central caseous necrosis. A relationship between the granuloma and the pilosebaceous unit was seen in 75.7% of cases. Epidermal changes, like acanthosis, were found in 47.1% of cases. We also report the existence of linear vessels in 25 (35.7%) cases. Conclusion: Most authors now consider LMDF a distinct entity, but because of its resemblance to other diseases like granulomatous rosacea, the diagnosis is challenging. Unlike many studies in this field, we provide a quite large sample and report telangiectasia in LMDF patients, which highlights the importance of precisely differentiating LMDF from rosacea. Delay in diagnosis and treatment increases the risk of scarring. Overall, we believe this study provides valuable insights into the demographics and histopathology of LMDF, contributing to the understanding of this challenging skin disorder.